Nippon India Pharma Fund - Direct - Growth

Equity Scheme by Nippon Life India Asset Management Limited

3Y Returns (CAGR)
18.68%
Expense Ratio
0.93%

as of 01/06/2026

AUM
₹2,128.02 Cr

Qtr End: Mar 26

NAV
₹630.362

as of 17/07/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M11.68%55.58%11.95%
6M13.37%28.52%13.55%
1Y8.32%8.32%12.52%
3Y67.14%18.68%13.03%
5Y91.84%13.92%13.14%
Scheme Details
Launch Date
10/05/2004
Fund Age
22.2 years
Minimum Investment
₹5,000
Fund House
Nippon India Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions